References
- COVIC A., VLAD C.E., CARUNTU I.D., VORONEANU L., HOGAS S., CUSAI S., et al., Epidemiology of biopsy-proven glomerulonephritis in the past 25 years in the North-Eastern area of Romania. International Urology, and Nephrology. 2022; 54(2): p. 365–76. DOI: 10.1007/s11255-021-02881-z
- VOLOVĂT C., CÃRUNTU I., COSTIN C., STEFAN A., POPA R., VOLOVĂT S., et al., Changes in the histological spectrum of glomerular diseases in the past 16 years in the North-Eastern region of Romania. BMC nephrology. 2013;14: p. 1–7. DOI: 10.1186/1471-2369-14-148
- PANĂ N., ȘTEFAN G., STANCU S., ZUGRAVU A., CIUREA O., PETRE N., et al., Clinicopathological Characteristics, and Disease Chronicity in Glomerular Diseases: A Decade-Long Study at Romania’s Largest Kidney Biopsy Reference Center. Biomedicines. 2024; 12(6): p. 1143. DOI: 10.3390/biomedicines12061143
- SETHI S., HAAS M., MARKOWITZ G.S., D’AGATI V.D., RENNKE H.G., JENNETTE J.C., et al., Mayo clinic/renal pathology society consensus report on pathologic classification, diagnosis, and reporting of GN. Journal of the American Society of Nephrology. 2016; 27(5): p. 1278–87. DOI: 10.1681/ASN.2015060612
- INKER L.A., ENEANYA N.D., CORESH J., TIGHIOUART H., WANG D., SANG Y., et al., New creatinine-and cystatin C– based equations to estimate GFR without race. New England Journal of Medicine. 2021; 385(19): p. 1737–49. DOI: 10.1056/NEJMoa2102953
- O’SHAUGHNESSY M.M., HOGAN S.L., THOMPSON B.D., COPPO R., FOGO A.B., JENNETTE J.C. Glomerular disease frequencies by race, sex, and region: results from the International Kidney Biopsy Survey. Nephrology Dialysis Transplantation. 2018; 33(4): p. 661–9. DOI: 10.1093/ndt/gfx189
- FIORENTINO M., BOLIGNANO D., TESAR V., PISANO A., VAN BIESEN W., D”ARRIGO G., et al., ERA-EDTA Immunonephrology Working Group. Renal biopsy in 2015-from epidemiology to evidence-based indications. American journal of nephrology. 2016; 43(1): p. 1–9. DOI: 10.1159/000444026
- MCQUARRIE E.P., MACKINNON B., YOUNG B., YEOMAN L., STEWART G., FLEMING S., et al., Scottish Renal Biopsy Registry. Centre variation in incidence, indication, and diagnosis of adult native renal biopsy in Scotland. Nephrology Dialysis Transplantation. 2009; 24(5): p. 1524–8. DOI: 10.1093/ndt/gfn677
- WIRTA O., MUSTONEN J., HELIN H., PASTERNACK A.. Incidence of biopsy-proven glomerulonephritis. Nephrology Dialysis Transplantation. 2008; 23(1): p. 193–200. DOI: 10.1093/ndt/gfm564
- BRIGANTI E.M., DOWLING J., FINLAY M., HILL P.A., JONES C.L., KINCAID‐SMITH P.S., et al., The incidence of biopsy‐proven glomerulonephritis in Australia. Nephrology Dialysis Transplantation. 2001; 16(7): p. 1364–7. DOI: 10.1093/ndt/16.7.1364
- NAUMOVIC R., PAVLOVIC S., STOJKOVIC D., BASTA-JOVANOVIC G., NESIC V. Renal biopsy registry from a single centre in Serbia: 20 years of experience. Nephrology Dialysis Transplantation. 2009; 24(3): p. 877–85. DOI: 10.1093/ndt/gfn564
- LÓPEZ-GÓMEZ J.M., RIVERA F. Spanish Registry of glomerulonephritis 2020 revisited: past, current data, and new challenges. Nefrología (English Edition). 2020; 40(4): p. 371–83. DOI: 10.1016/j.nefro.2020.04.012
- MAIXNEROVA D., JANCOVA E., SKIBOVA J., RYSAVA R., RYCHLIK I., VIKLICKY O., et al., Nationwide biopsy survey of renal diseases in the Czech Republic during the years 1994–2011. Journal of nephrology. 2015; 28: p. 39–49. DOI: 10.1007/s40620-014-0090-z
- PERKOWSKA-PTASINSKA A., BARTCZAK A., WAGROWSKA-DANILEWICZ M., HALON A., OKON K., WOZNIAK A., et al., Clinicopathologic correlations of renal pathology in the adult population of Poland. Nephrology Dialysis Transplantation. 2017; 32: p. 209–18. DOI: 10.1093/ndt/gfw365
- LAURENS W., DELEERSNIJDER D., DENDOOVEN A., LERUT E., DE VRIESE A.S., DEJAGERE T., et al., Epidemiology of native kidney disease in Flanders: results from the FCGG kidney biopsy registry. Clinical Kidney Journal. 2022; 15(7): p. 1361–72. DOI: 10.1093/ckj/sfac033
- SAHA M.K., MASSICOTTE-AZARNIOUCH D., REYNOLDS M.L., MOTTL AK, FALK R.J., JENNETTE J.C., et al., Glomerular hematuria, and the utility of urine microscopy: a review. American Journal of Kidney Diseases. 2022; 80(3): p. 383–92. DOI: 10.1053/j.ajkd.2022.02.022
- NAJAFIAN B., LUSCO M.A., ALPERS C.E., FOGO A.B. Approach to kidney biopsy: core curriculum 2022. American Journal of Kidney Diseases. 2022; 80(1): p. 119–31. DOI: 10.1053/j.ajkd.2021.08.024.
- SCHENA F.P. Survey of the Italian Registry of Renal Biopsies. Frequency of the renal diseases for 7 consecutive years. The Italian Group of Renal Immunopathology. Nephrology, dialysis, transplantation: official publication of the European Dialysis, and Transplant Association-European Renal Association. 1997; 12(3): p. 418–26. DOI: 10.1093/ndt/12.3.418
- ZINK C.M., ERNST S., RIEHL J., HELMCHEN U., GRÖNE H.J., FLOEGE J., et al., Trends of renal diseases in Germany: review of a regional renal biopsy database from 1990 to 2013. Clinical Kidney Journal. 2019; 12(6): p. 795–800. DOI: 10.1093/ckj/sfz023
- BRAZDŽIŪTĖ E., MIGLINAS M., GRUODYTĖ E., PRILUCKIENĖ J., TAMOŠAITIS A., BUMBLYTĖ I.A., et al., Nationwide renal biopsy data in Lithuania 1994–2012. International urology, and nephrology. 2015, 47(4): p. 655–662. DOI: 10.1007/s11255-015-0927-y
- PITCHER D., BRADDON F., HENDRY B., MERCER A., OSMASTON K., SALEEM M.A., et al., Long-term outcomes in IgA nephropathy. Clinical Journal of the American Society of Nephrology. 2023; 18(6): p. 727–38. DOI: 10.2215/CJN.0000000000000135
- CASTER D.J., ABNER C.W., WALKER P.D., WANG K., HEO J., RAVA A.R., et al., Clinicopathological Characteristics of Adult IgA Nephropathy in the United States. Kidney International Reports. 2023; 8(9): p. 1792–800. DOI: 10.1016/j.ekir.2023.06.016.
- KNOOP T., VIKSE B.E., MWAKIMONGA A., LEH S., BJØRNEKLETT R. Long-term outcome in 145 patients with assumed benign immunoglobulin A nephropathy. Nephrology Dialysis Transplantation. 2017; 32(11): p. 1841–50. DOI: 10.1093/ndt/gfx242
- O’SHAUGHNESSY M.M., HOGAN S.L., POULTON C.J., FALK R.J., SINGH H.K., NICKELEIT V., et al., Temporal, and demographic trends in glomerular disease epidemiology in the Southeastern United States, 1986–2015. Clinical Journal of the American Society of Nephrology. 2017; 12(4): p. 614–23. DOI: 10.2215/CJN.10871016
- OBRIȘCĂ B., ȘTEFAN G., GHERGHICEANU M., MANDACHE E., ISMAIL G., STANCU S., et al., “Associated” or “Secondary” IgA nephropathy? An outcome analysis. PLoS One. 2019; 14(8):e0221014. DOI: 10.1371/journal.pone.0221014